Cost-effectiveness analysis of infliximab, adalimumab,...

  • Main
  • 2017 / 12
  • Cost-effectiveness analysis of infliximab, adalimumab,...
Expert Review of Pharmacoeconomics & Outcomes Research 2017 / 12

Cost-effectiveness analysis of infliximab, adalimumab, golimumab and vedolizumab for moderate to severe ulcerative colitis in Spain

Trigo-Vicente, Cristina, Gimeno-Ballester, Vicente, Montoiro-Allué, Raquel, López-Del Val, Alejandro
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Language:
english
Journal:
Expert Review of Pharmacoeconomics & Outcomes Research
DOI:
10.1080/14737167.2018.1411193
Date:
December, 2017
File:
PDF, 1.67 MB
english, 2017
Conversion to is in progress
Conversion to is failed